Little is known about LRIG2, although it has been shown to be permissive for glial tumour growth in vivo [49], and in a glioma cell culture model, LRIG2 interacts with epidermal growth factor receptor and modulates intracellular signalling [50]. Here, LRIG2 is linked to central nervous system cancer.